Alphamab Oncology announced that anti-HER2 biparatopic antibody-drug conjugate JSKN003 has been granted Orphan Drug Designation by the FDA for the treatment of gastric cancer and gastroesophageal junction cancer (GC/GEJ).
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced a strategic collaboration with the German Center for Neurodegenerative Diseases.